Evidence map›Paper›PMID 42027422›Full record

ArticleBiophotonics discovery2025

Single-cell Raman spectroscopy detects pediatric focal cortical dysplasia.

Trang Tran, Frederick Dallaire, Joshua Sonnen, Romain Cayrol, Frédéric Leblond, Roy W R Dudley

Abstract read
In one paragraph

Article in Biophotonics discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Trang TranPolytechnique Montréal, Department of Engineering Physics, Montréal, Quebec, Canada.ORCID https://orcid.org/0000-0002-4251-7804
Frederick DallairePolytechnique Montréal, Department of Engineering Physics, Montréal, Quebec, Canada.ORCID https://orcid.org/0000-0002-3333-9014
Joshua SonnenMcGill University Health Center (MUHC), Department of Pathology, Montréal, Quebec, Canada.
Romain CayrolCentre Hospitalier Universitaire de l'Université de Montréal (CHUM), Department of Pathology, Montréal, Quebec, Canada.
Frédéric LeblondPolytechnique Montréal, Department of Engineering Physics, Montréal, Quebec, Canada.ORCID https://orcid.org/0000-0002-8154-4952
Roy W R DudleyMcGill University Health Center (MUHC), Department of Neurosurgery, Montréal, Quebec, Canada.ORCID https://orcid.org/0000-0003-4437-0823

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significance: Focal cortical dysplasia (FCD) type II is the leading cause of drug-resistant focal epilepsy in children. While surgical resection offers the only definitive cure, its success is hindered by the challenge of precisely identifying the lesion and its boundaries. Despite advancements in neuroimaging, FCD type II often remains elusive, complicating surgical planning and outcome optimization. Enhanced detection methods are crucial to improving the precision of resection and, ultimately, achieving seizure freedom in affected patients. Aim: Advanced techniques for detecting FCD type II margins during surgery are critically needed to enhance postoperative outcomes. Spontaneous Raman spectroscopy is a label-free optical method that allows the characterization of the tissue's biochemical composition. The goal of this proof-of-concept study was to compare-in pediatric patients-the spectral signature of abnormal cells in FCD tissue with cells associated with the normal cortex. Approach: A Raman microspectroscopy imaging workflow was developed and applied to 70 surgical specimens from 30 focal epilepsy patients diagnosed with FCD type II. Raman spectra from individual cells were recorded from FCD type II specimens (dysmorphic neurons and balloon cells) and normal brains (neurons). Machine learning models (support vector machines) were trained, validated, and tested to distinguish FCD tissue from the normal brain as well as to distinguish between two disease subtypes, i.e., FCD types IIa and IIb. Results: A total of 1420 single-cell spectra were acquired and spectral differences determined between FCD type II and normal cortex, as well as between FCD type IIa and type IIb. Machine learning distinguished FCD type II from the normal cortex with 96% accuracy, 100% sensitivity, and 95% specificity. FCD types IIa and IIb specimens were distinguished with 92% accuracy, 100% sensitivity, and 86% specificity. Conclusions: The Raman spectroscopy signature of single cells associated with FCD tissue was established. This provides credence to the hypothesis that Raman spectroscopy as a technique-if implemented using a fiber optics system-has the potential for safely optimizing the extent of FCD type II resection in pediatric focal epilepsy surgery. In addition, this technique provides insights into multiple biochemical alterations within dysplastic tissues, which may contribute to the underlying mechanisms of epileptogenesis.

Indexed as

epilepsyfocal cortical dysplasiamachine learningmicroscopyRaman spectroscopytissue optics

Identifiers

PMID42027422
PMCPMC13098737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.